Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole and Escitalopram in Major Depressive Disorder
NCT00086307Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jun 2004
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pramipexole, escitalopram in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Jun 2004; status: completed.
02
Drugs
pramipexoleescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00086307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086307.